Enhancing the rational use of new medicines across European health care systems-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing the rational use of new medicines across European health care systems

Published:2008-08-08 Issue:12 Volume:64 Page:1137-1138
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Garattini Silvio,Bertele’ Vittorio,Godman Brian,Haycox Alan,Wettermark Björn,Gustafsson Lars L.,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-008-0537-z.pdf

Reference6 articles.

1. Garattini L, Motterlini N, Cornago D (2008) Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries. Health Policy 85:305–813

2. Lee TH, Emanuel EJ (2008) Tier 4 drugs and the fraying of the social compact. New Engl J Medicine 359:333–335

3. Jack A (2008) Balancing big pharma’s books. BMJ 336:418–419

4. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine – selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326:1171–1173

5. Chan A-W, Hróbjartsson A, Haaber M, Gøtzsche P, Altman D (2004) Empirical evidence for selective reporting of outcomes in randomised trials. JAMA 291:2457–2465

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries;Frontiers in Pharmacology;2022-06-16

2. European collaborations on medicine and vaccine procurement;Bulletin of the World Health Organization;2021-10-01

3. Integrative Review of Managed Entry Agreements: Chances and Limitations;PharmacoEconomics;2020-07-31

4. Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions;Frontiers in Pharmacology;2020-03-03

5. Pricing of oral generic cancer medicines in 25 European countries; findings and implications;Generics and Biosimilars Initiative Journal;2019-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3